Review



computer‐generated randomisation schedule  (Glaxo Smith)

 
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Glaxo Smith computer‐generated randomisation schedule
    <xref ref-type= Lacerda 2019 " width="250" height="auto" />
    Computer‐Generated Randomisation Schedule, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%90generated+randomisation+schedule/computer+generated+randomization+schedule/pmc08094590-85-16-20
    Average 90 stars, based on 1 article reviews
    computer‐generated randomisation schedule - by Bioz Stars, 2026-11
    90/100 stars

    Images

    1) Product Images from "Tafenoquine for preventing relapse in people with Plasmodium vivax malaria"

    Article Title: Tafenoquine for preventing relapse in people with Plasmodium vivax malaria

    Journal: The Cochrane Database of Systematic Reviews

    doi: 10.1002/14651858.CD010458.pub3

    <xref ref-type= Lacerda 2019 " title="Lacerda 2019" property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Lacerda 2019

    Techniques Used: Activity Assay, Infection, Sequencing, Selection

    <xref ref-type= Llanos‐Cuentas 2014 " title="Llanos‐Cuentas 2014" property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Llanos‐Cuentas 2014

    Techniques Used: Activity Assay, Infection, Sequencing, Selection, Generated

    Related Articles

    Sequencing:

    Article Title: Drugs for the acute treatment of migraine in children and adolescents
    Article Snippet: Allocation concealment (selection bias) , Low risk , Quote: "randomization schedule prepared by the sponsor" Comment: centralized allocation. .. Random sequence generation (selection bias) , Low risk , Quote: "randomized in a 1:1:1 ratio (in blocks of six) to one of three treatment groups"; "computer‐generated randomization schedule" Comment: previous migraine studies by GlaxoSmithKline have documented acceptable sequence generation (e.g. Winner 2000 ). .. Allocation concealment (selection bias) , Low risk , Quote: "randomization schedule prepared by the sponsor" Comment: centralized allocation.

    Article Title: Vaccines for preventing rotavirus diarrhoea: vaccines in use
    Article Snippet: Seroconversion: appearance of anti-rotavirus IgA antibody concentration ≥ 20 U/mL in participants seronegative for rotavirus before vaccination (review includes data from 1 to 2 months after dose 2) Immunization status Concomitant vaccines included 7 valent pneumococcal polysaccharide conjugate vaccine (Prevenar) and meningococcal group c conjugate vaccine (Meningitec); Hepatitis B vaccine, diphtheria-tetanusacellular pertussis, polio virus, and H. influenzae type b vaccines were co-administered Location 98 centres in 6 European countries (Czech Republic, Finland, France, Germany, Italy, and Spain) WHO mortality stratum A Notes Date: 12 February 2007 to 08 August 2007 Source of funding: funded by GlaxoSmithKline Biologicals Other: vaccination postponed if baby either had a temperature of ≥ 37.5 °C (axillary) or of 38.0 °C (rectal) or had gastroenteritis within 7 days before planned vaccination Study aim: "to assess the efficacy and safety of HRV [RV1] vaccine during the 3rd year of age in subjects primed with a 2-dose schedule in study 102247, with the first dose administered at the age of 6 to 14 weeks" .. Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Quote: "GSK Biologicals provided vaccine supplies that were numbered with a computer-generated randomization list" Allocation concealment (selection bias) Low risk Quote: "randomization was done by a central Internet randomization system. ..

    Article Title: Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
    Article Snippet: .. Random sequence generation (selection bias) , Low risk , Quote: "With the use of a computer‐generated randomisation schedule provided by GlaxoSmithKline, on day 1 eligible participants were randomly assigned, in a 2:1:1 ratio...". .. Allocation concealment (selection bias) , Low risk , Quote: "Patients and trial staff were unaware of the group assignments.".

    Selection:

    Article Title: Drugs for the acute treatment of migraine in children and adolescents
    Article Snippet: Allocation concealment (selection bias) , Low risk , Quote: "randomization schedule prepared by the sponsor" Comment: centralized allocation. .. Random sequence generation (selection bias) , Low risk , Quote: "randomized in a 1:1:1 ratio (in blocks of six) to one of three treatment groups"; "computer‐generated randomization schedule" Comment: previous migraine studies by GlaxoSmithKline have documented acceptable sequence generation (e.g. Winner 2000 ). .. Allocation concealment (selection bias) , Low risk , Quote: "randomization schedule prepared by the sponsor" Comment: centralized allocation.

    Article Title: Vaccines for preventing rotavirus diarrhoea: vaccines in use
    Article Snippet: Seroconversion: appearance of anti-rotavirus IgA antibody concentration ≥ 20 U/mL in participants seronegative for rotavirus before vaccination (review includes data from 1 to 2 months after dose 2) Immunization status Concomitant vaccines included 7 valent pneumococcal polysaccharide conjugate vaccine (Prevenar) and meningococcal group c conjugate vaccine (Meningitec); Hepatitis B vaccine, diphtheria-tetanusacellular pertussis, polio virus, and H. influenzae type b vaccines were co-administered Location 98 centres in 6 European countries (Czech Republic, Finland, France, Germany, Italy, and Spain) WHO mortality stratum A Notes Date: 12 February 2007 to 08 August 2007 Source of funding: funded by GlaxoSmithKline Biologicals Other: vaccination postponed if baby either had a temperature of ≥ 37.5 °C (axillary) or of 38.0 °C (rectal) or had gastroenteritis within 7 days before planned vaccination Study aim: "to assess the efficacy and safety of HRV [RV1] vaccine during the 3rd year of age in subjects primed with a 2-dose schedule in study 102247, with the first dose administered at the age of 6 to 14 weeks" .. Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Quote: "GSK Biologicals provided vaccine supplies that were numbered with a computer-generated randomization list" Allocation concealment (selection bias) Low risk Quote: "randomization was done by a central Internet randomization system. ..

    Article Title: Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
    Article Snippet: .. Random sequence generation (selection bias) , Low risk , Quote: "With the use of a computer‐generated randomisation schedule provided by GlaxoSmithKline, on day 1 eligible participants were randomly assigned, in a 2:1:1 ratio...". .. Allocation concealment (selection bias) , Low risk , Quote: "Patients and trial staff were unaware of the group assignments.".

    other:

    Article Title: A phase 2a, randomized, crossover trial of gabapentin enacarbil for the treatment of postherpetic neuralgia in gabapentin inadequate responders.
    Article Snippet: The computer-generated randomization schedule (block size 4) was stratified by center and provided by GlaxoSmithKline (Research Triangle Park, NC, USA).

    Article Title: Single-Dose Tafenoquine to Prevent Relapse ofPlasmodium vivaxMalaria
    Article Snippet: With the use of a computer-generated randomization schedule provided by GlaxoSmithKline, on day 1 eligible participants were randomly assigned, in a 2:1:1 ratio, to receive tafenoquine, primaquine, or placebo.

    Article Title: Tocolytics for delaying preterm birth: a network meta-analysis (0924)
    Article Snippet: Funded by GlaxoSmithKline Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Computer-generated randomisation Allocation concealment (selection bias) Low risk Infusions and matching placebos were prepared by unblinded pharmacists/qualified individuals Saade 2021 Tocolytics for delaying preterm birth: a network meta-analysis (0924) (Review) Copyright © 2022 The Cochrane Collaboration.

    Article Title: Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial
    Article Snippet: Patients were randomised centrally across all sites in accordance with a computer-generated randomisation schedule validated by GlaxoSmithKline.



    Similar Products

    90
    Veristat Inc computer-generated participant identification number and randomisation schedule with block randomisation
    Computer Generated Participant Identification Number And Randomisation Schedule With Block Randomisation, supplied by Veristat Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%90generated+randomisation+schedule/computer+generated+participant+identification+number+and+randomisation+schedule+with+block+randomisation/10__1016_slash_s0140___6736_ascii40_23_ascii41_02190___6-67-22-8
    Average 90 stars, based on 1 article reviews
    computer-generated participant identification number and randomisation schedule with block randomisation - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Janssen computer-generated randomisation schedule
    Computer Generated Randomisation Schedule, supplied by Janssen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%90generated+randomisation+schedule/randomisation+sequence/10__1016_slash_s0140___6736_ascii40_22_ascii41_00688___2-39-6-19
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation schedule - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Glaxo Smith computer‐generated randomisation schedule
    <xref ref-type= Lacerda 2019 " width="250" height="auto" />
    Computer‐Generated Randomisation Schedule, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%90generated+randomisation+schedule/computer+generated+randomization+schedule/pmc08094590-85-16-20
    Average 90 stars, based on 1 article reviews
    computer‐generated randomisation schedule - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    SAS institute computer-generated randomisation schedules
    <xref ref-type= Lacerda 2019 " width="250" height="auto" />
    Computer Generated Randomisation Schedules, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%90generated+randomisation+schedule/computer+generated+randomization+list/10__1016_slash_s1473___3099_ascii40_20_ascii41_30023___2-72-7-15
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation schedules - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Pfizer Inc computer-generated randomised schedule
    <xref ref-type= Lacerda 2019 " width="250" height="auto" />
    Computer Generated Randomised Schedule, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%90generated+randomisation+schedule/computer+generated+randomisation+list/pmc06614921-2004-24-4
    Average 90 stars, based on 1 article reviews
    computer-generated randomised schedule - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc computer generated randomisation schedule
    <xref ref-type= Lacerda 2019 " width="250" height="auto" />
    Computer Generated Randomisation Schedule, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%90generated+randomisation+schedule/computer+generated+randomization+list/pmc06375188-78-17-12
    Average 90 stars, based on 1 article reviews
    computer generated randomisation schedule - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    STATA Corporation computer-generated randomised treatment allocation schedule
    The count of strata incorporated within the <t> block-randomised </t> 1:1 hypothermia / normothermia <t> treatment allocation schedule </t>
    Computer Generated Randomised Treatment Allocation Schedule, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%90generated+randomisation+schedule/computer+generated+randomised+treatment+allocation+schedule/pmc05923032-66-2-7
    Average 90 stars, based on 1 article reviews
    computer-generated randomised treatment allocation schedule - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Glaxo Smith computer-generated randomisation schedule
    The count of strata incorporated within the <t> block-randomised </t> 1:1 hypothermia / normothermia <t> treatment allocation schedule </t>
    Computer Generated Randomisation Schedule, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%90generated+randomisation+schedule/computer+generated+randomization+schedule/10__1016_slash_s1474___4422_ascii40_16_ascii41_30399___4-28-11-16
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation schedule - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Almirall Hermal computer generated randomisation schedule
    ACCLAIM/COPD I
    Computer Generated Randomisation Schedule, supplied by Almirall Hermal, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%90generated+randomisation+schedule/computer+generated+randomisation+schedule/pmc08922974-902-16-11
    Average 90 stars, based on 1 article reviews
    computer generated randomisation schedule - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    <xref ref-type= Lacerda 2019 " width="100%" height="100%">

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tafenoquine for preventing relapse in people with Plasmodium vivax malaria

    doi: 10.1002/14651858.CD010458.pub3

    Figure Lengend Snippet: Lacerda 2019

    Article Snippet: Random sequence generation (selection bias) , Low risk , Quote: "With the use of a computer‐generated randomisation schedule provided by GlaxoSmithKline, on day 1 eligible participants were randomly assigned, in a 2:1:1 ratio…".

    Techniques: Activity Assay, Infection, Sequencing, Selection

    <xref ref-type= Llanos‐Cuentas 2014 " width="100%" height="100%">

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tafenoquine for preventing relapse in people with Plasmodium vivax malaria

    doi: 10.1002/14651858.CD010458.pub3

    Figure Lengend Snippet: Llanos‐Cuentas 2014

    Article Snippet: Random sequence generation (selection bias) , Low risk , Quote: "With the use of a computer‐generated randomisation schedule provided by GlaxoSmithKline, on day 1 eligible participants were randomly assigned, in a 2:1:1 ratio…".

    Techniques: Activity Assay, Infection, Sequencing, Selection, Generated

    The count of strata incorporated within the  block-randomised  1:1 hypothermia / normothermia  treatment allocation schedule

    Journal: Trials

    Article Title: Statistical analysis plan for the POLAR-RCT: The Prophylactic hypOthermia trial to Lessen trAumatic bRain injury-Randomised Controlled Trial

    doi: 10.1186/s13063-018-2610-y

    Figure Lengend Snippet: The count of strata incorporated within the block-randomised 1:1 hypothermia / normothermia treatment allocation schedule

    Article Snippet: The computer-generated randomised treatment allocation schedule (using Stata version 11 ralloc module http://fmwww.bc.edu/repec/bocode/r/ralloc.ado ) [ ] was stratified by hospital group or pre-hospital paramedic ambulance service with a permuted block scheme.

    Techniques: Blocking Assay, Western Blot

    ACCLAIM/COPD I

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD010509.pub2

    Figure Lengend Snippet: ACCLAIM/COPD I

    Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

    Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

    ACCLAIM/COPD II

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD010509.pub2

    Figure Lengend Snippet: ACCLAIM/COPD II

    Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

    Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

    ACCORD COPD I

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD010509.pub2

    Figure Lengend Snippet: ACCORD COPD I

    Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

    Techniques: Control, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

    ACCORD COPD II

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD010509.pub2

    Figure Lengend Snippet: ACCORD COPD II

    Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

    Techniques: Control, Infection, Comparison, Medications, Concentration Assay, Sequencing, Selection, Generated, Blocking Assay

    ACLIFORM

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD010509.pub2

    Figure Lengend Snippet: ACLIFORM

    Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

    Techniques: Control, Infection, Transplantation Assay, Functional Assay, Comparison, Sequencing, Selection, Generated, Blocking Assay

    ATTAIN

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD010509.pub2

    Figure Lengend Snippet: ATTAIN

    Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

    Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

    AUGMENT COPD

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD010509.pub2

    Figure Lengend Snippet: AUGMENT COPD

    Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

    Techniques: Control, Infection, Comparison, Sequencing, Selection, Generated, Blocking Assay

    Beier 2013

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD010509.pub2

    Figure Lengend Snippet: Beier 2013

    Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

    Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

    Chanez 2010

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD010509.pub2

    Figure Lengend Snippet: Chanez 2010

    Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

    Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Activity Assay, Sequencing, Selection, Generated, Blocking Assay

    NCT01572792

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD010509.pub2

    Figure Lengend Snippet: NCT01572792

    Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

    Techniques: Control, Comparison, Sequencing, Selection, Generated, Blocking Assay

    Sliwinski 2010

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD010509.pub2

    Figure Lengend Snippet: Sliwinski 2010

    Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

    Techniques: Control, Comparison, Sequencing, Selection